TORONTO, May 3, 2016 /CNW/ - Gerald Solensky, Jr., Chief Executive Officer,
Zomedica Pharmaceuticals Corp. (ZOM) joined Richard Rohan, VP, Corporate Sales, TMX Equity
Transfer & Trust Company to open the market. Zomedica is a
veterinary pharmaceutical company based in Ann Arbor, Michigan, targeting health and
wellness solutions for companion animals (canine, feline and
equine) through an approach that focuses on the needs of clinical
veterinarians. Zomedica Pharmaceuticals Corp. commenced trading on
TSX Venture Exchange on May 2,
2016.
SOURCE Toronto Stock Exchange
Image with caption: "Gerald Solensky,
Jr., Chief Executive Officer, Zomedica Pharmaceuticals Corp.
(ZOM) joined Richard Rohan, VP,
Corporate Sales, TMX Equity Transfer & Trust Company to open
the market. Zomedica is a veterinary pharmaceutical company based
in Ann Arbor, Michigan, targeting
health and wellness solutions for companion animals (canine, feline
and equine) through an approach that focuses on the needs of
clinical veterinarians. Zomedica Pharmaceuticals Corp. commenced
trading on TSX Venture Exchange on May 2,
2016. (CNW Group/TMX Group Limited) (CNW Group/Toronto Stock
Exchange)". Image available at:
http://photos.newswire.ca/images/download/20160503_C9163_PHOTO_EN_44739.jpg